Gilead, Aelix ally to trial HIV-suppressing combination

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 18, 2018 at 11:22 AM.

  1. #1 cafead, Oct 18, 2018 at 11:22 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,932
    Likes Received:
    3
    via Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7 agonist in combination with Aelix’s T-cell vaccine.

    article source
     
    Quote

Reply to Thread